Lehman & Derafelo Financial Resources LLC Gilead Sciences, Inc. Transaction History

Lehman & Derafelo Financial Resources LLC

$337 Million
Q4 2022

A detailed history of Lehman & Derafelo Financial Resources LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Lehman & Derafelo Financial Resources LLC holds 26,777 shares of GILD stock, worth $2.52 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

26,777

Previous 27,577 2.9%

Holding current value

$2.52 Million

Previous $1.7 Million 35.1%

% of portfolio

0.68%

Previous 0.54%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 20, 2023	SELL	$62.32 - $89.47 $49,856 - $71,576	-800 Reduced 2.9%	26,777 $0
Q3 2022 Oct 21, 2022	BUY	$59.54 - $68.01 $35,724 - $40,806	600 Added 2.22%	27,577 $1.7 Million
Q2 2022 Jul 19, 2022	BUY	$57.72 - $65.01 $68,686 - $77,361	1,190 Added 4.61%	26,977 $1.67 Million
Q1 2022 Apr 21, 2022	BUY	$57.92 - $72.58 $62,959 - $78,894	1,087 Added 4.4%	25,787 $1.53 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $7,785 - $8,836	120 Added 0.49%	24,700 $1.79 Million
Q3 2021 Oct 28, 2021	BUY	$67.69 - $73.03 $16,922 - $18,257	250 Added 1.03%	24,580 $1.72 Million
Q2 2021 Jul 19, 2021	BUY	$63.47 - $69.35 $9,520 - $10,402	150 Added 0.62%	24,330 $1.68 Million
Q1 2021 Apr 21, 2021	SELL	$60.0 - $68.46 $18,000 - $20,537	-300 Reduced 1.23%	24,180 $1.56 Million
Q4 2020 Jan 20, 2021	BUY	$56.65 - $64.55 $44,753 - $50,994	790 Added 3.33%	24,480 $1.43 Million
Q3 2020 Nov 06, 2020	BUY	$62.1 - $78.08 $40,675 - $51,142	655 Added 2.84%	23,690 $1.5 Million
Q2 2020 Jul 30, 2020	BUY	$72.34 - $84.0 $5,425 - $6,300	75 Added 0.33%	23,035 $1.77 Million
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $62 - $80	1 Added 0.0%	22,960 $1.72 Million
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $9,304 - $10,234	151 Added 0.66%	22,959 $1.49 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $62 - $69	1 Added 0.0%	22,808 $1.45 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $30,873 - $34,620	-499 Reduced 2.14%	22,807 $1.56 Million
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $93,857 - $105,145	1,501 Added 6.88%	23,306 $1.52 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $1.32 Million - $1.72 Million	21,805 New	21,805 $1.36 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lehman & Derafelo Financial Resources LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lehman & Derafelo Financial Resources LLC with notifications on news.

Account

Lehman & Derafelo Financial Resources LLC Gilead Sciences, Inc. Transaction History